Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 1
2012 1
2013 1
2014 2
2016 2
2017 1
2020 2
2021 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
[Misuse and dependence on prescription opioids: Prevention, identification and treatment].
Rolland B, Bouhassira D, Authier N, Auriacombe M, Martinez V, Polomeni P, Brousse G, Schwan R, Lack P, Bachellier J, Rostaing S, Bendimerad P, Vergne-Salle P, Dematteis M, Perrot S. Rolland B, et al. Among authors: bachellier j. Rev Med Interne. 2017 Aug;38(8):539-546. doi: 10.1016/j.revmed.2016.12.024. Epub 2017 Feb 15. Rev Med Interne. 2017. PMID: 28214183 Review. French.
Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.
Rolland B, Trojak B, Nourredine M, Bachellier J, Chappuy M, Bendimerad P, Kosim M, Hjelmström P, Meroueh F, Nubukpo P, Brousse G. Rolland B, et al. Among authors: bachellier j. Drug Alcohol Depend. 2021 Mar 1;220:108492. doi: 10.1016/j.drugalcdep.2020.108492. Epub 2021 Jan 8. Drug Alcohol Depend. 2021. PMID: 33482572 Free article.
Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.
Chappuy M, Meroueh F, Trojak B, Bachellier J, Bendimerad P, Kosim M, Hjelmström P, Nubukpo P, Brousse G, Rolland B. Chappuy M, et al. Among authors: bachellier j. Patient Prefer Adherence. 2021 Jun 14;15:1259-1267. doi: 10.2147/PPA.S311674. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34163143 Free PMC article.
Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study.
Daulouède JP, Caer Y, Galland P, Villeger P, Brunelle E, Bachellier J, Piquet JM, Harbonnier J, Leglise Y, Courty P. Daulouède JP, et al. Among authors: bachellier j. J Subst Abuse Treat. 2010 Jan;38(1):83-9. doi: 10.1016/j.jsat.2009.07.002. Epub 2009 Oct 2. J Subst Abuse Treat. 2010. PMID: 19800758
12 results